Date Filed | Type | Description |
10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
10-Q
| Quarterly Report for the period ended August 31, 2023 |
10/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
08/22/2023 |
4
| BOEHM WILLIAM T (Director) has filed a Form 4 on NEOGEN CORP
Txns:
| Sold 1,500 shares
@ $22.5939, valued at
$33.9k
Exercised 1,500 options to buy
@ $15.62, valued at
$23.4k
|
|
08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
10-K
| Annual Report for the period ended May 31, 2023 |
07/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
07/27/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/04/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
03/30/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2023 |
4
| BOEHM WILLIAM T (Director) has filed a Form 4 on NEOGEN CORP
Txns:
| Exercised 750 shares
@ $20.08, valued at
$15.1k
Exercised 1,500 options to buy
@ $15.62, valued at
$23.4k
|
|
01/23/2023 |
SC 13G/A
| BlackRock Inc. reports a 11.3% stake in NEOGEN CORP |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/09/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
01/05/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/23/2022 |
3
| Naemura David H. (VP & CFO) has filed a Form 3 on NEOGEN CORP |
12/23/2022 |
3
| Rocklin Amy M (Chief Legal & Reg. Officer) has filed a Form 3 on NEOGEN CORP |
11/30/2022 |
8-K
| Quarterly results |
10/11/2022 |
4
| Quinlan Steven J. (VP & CFO) has filed a Form 4 on NEOGEN CORP
Txns:
| Bought 5,000 shares
@ $11.63, valued at
$58.2k
|
|
10/11/2022 |
4
| Hagedorn Jerome L (Vice President) has filed a Form 4 on NEOGEN CORP
Txns:
| Exercised 20,313 options to buy
@ $13.28, valued at
$269.8k
Exercised 6,853 restricted stock units
@ $13.28, valued at
$91k
|
|
10/11/2022 |
4
| Lilly Jason Warren (Vice President, International) has filed a Form 4 on NEOGEN CORP
Txns:
| Exercised 41,965 options to buy
@ $13.28, valued at
$557.3k
Exercised 14,157 restricted stock units
@ $13.28, valued at
$188k
|
|
10/11/2022 |
4
| Jones Douglas Edward (COO) has filed a Form 4 on NEOGEN CORP
Txns:
| Exercised 165,105 options to buy
@ $13.28, valued at
$2.2M
Exercised 37,133 restricted stock units
@ $13.28, valued at
$493.1k
|
|
10/11/2022 |
4
| ADENT JOHN EDWARD (President & CEO) has filed a Form 4 on NEOGEN CORP
Txns:
| Exercised 625,001 options to buy
@ $13.28, valued at
$8.3M
Exercised 90,361 restricted stock units
@ $13.28, valued at
$1.2M
|
|
|